Pantoprazole sodium delayed-release tablets are indicated for: Pantoprazole sodium is a proton pump inhibitor (PPI) indicated for the following: Short-Term Treatment of Erosive Esophagitis Associated with Gastroesophageal Reflux Disease (GERD) Maintenance of Healing of Erosive Esophagitis Pathological Hypersecretory Conditions Including Zollinger-Ellison (ZE) Syndrome 1.1 Short-Term Treatment of Erosive Esophagitis Associated With Gastroesophageal Reflux Disease (GERD) Pantoprazole sodium is indicated in adults and pediatric patients five years of age and older for the short-term treatment (up to 8 weeks) in the healing and symptomatic relief of erosive esophagitis (EE).
From the U.S. FDA-approved label for Pantoprazole. Full label: DailyMed.
Pantoprazole sodium delayed-release tablets are indicated for: Pantoprazole sodium is a proton pump inhibitor (PPI) indicated for the following: Short-Term Treatment of Erosive Esophagitis Associated with Gastroesophageal Reflux Disease (GERD) Maintenance of Healing of Erosive Esophagitis Pathological Hypersecretory Conditions Including Zollinger-Ellison (ZE) Syndrome 1.1 Short-Term Treatment of Erosive Esophagitis Associated With Gastroesophageal Reflux Disease (GERD) Pantoprazole sodium is indicated in adults and pediatric patients five years of age and older for the short-term treatment (up to 8 weeks) in the healing and symptomatic relief of erosive esophagitis (EE). For those adult patients who have not healed after 8 weeks of treatment, an additional 8-week course of pantoprazole sodium delayed-release tablets may be considered. Safety of treatment beyond 8 weeks in pediatric patients has not been established. 1.2 Maintenance of Healing of Erosive Esophagitis Pantoprazole sodium delayed-release tablets are indicated for maintenance of healing of EE and reduction in relapse rates of daytime and nighttime heartburn symptoms in adult patients with GERD. Controlled studies did not extend beyond 12 months.
From the U.S. FDA-approved label for Pantoprazole. Full label: DailyMed.
Indication Dose Frequency Short-Term Treatment of Erosive Esophagitis Associated With GERD Adults 40 mg Once Daily for up to 8 weeks Children (5 years and older) ≥15 kg to < 40 kg 20 mg Once Daily for up to 8 weeks ≥ 40 kg 40 mg Maintenance of Healing of Erosive Esophagitis Adults 40 mg Once Daily* Pathological Hypersecretory Conditions Including Zollinger-Ellison Syndrome Adults 40 mg Twice Daily * Controlled studies did not extend beyond 12 months See full prescribing information for administration instructions 2.1 Recommended Dosing Schedule Pantoprazole sodium is supplied as delayed-release tablets.
Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.
Pantoprazole sodium is contraindicated in patients with known hypersensitivity to any component of the formulation or any substituted benzimidazole. Hypersensitivity reactions may include anaphylaxis, anaphylactic shock, angioedema, bronchospasm, acute tubulointerstitial nephritis, and urticaria. Proton pump inhibitors (PPIs), including pantoprazole sodium is contraindicated in patients receiving rilpivirine-containing products.
Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.
Gastric Malignancy: In adults, symptomatic response does not preclude presence of gastric malignancy. Consider additional follow-up and diagnostic testing. Acute Tubulointerstitial Nephritis: Discontinue treatment and evaluate patients. Clostridium difficile- Associated Diarrhea: PPI therapy may be associated with increased risk of Clostridium difficile -associated diarrhea. Bone Fracture: Long-term and multiple daily dose PPI therapy may be associated with an increased risk for osteoporosis-related fractures of the hip, wrist or spine.
Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.
The following serious adverse reactions are described below and elsewhere in labeling: Acute Tubulointerstitial Nephritis Clostridium difficile -Associated Diarrhea Bone Fracture Severe Cutaneous Adverse Reactions Cutaneous and Systemic Lupus Erythematosus Cyanocobalamin (Vitamin B-12) Deficiency Hypomagnesemia and Mineral Metabolism Fundic Gland Polyps Most common adverse reactions are: For adult use (> 2%): headache,…
Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.
2631 products from 1865 makers in the NepalDoc medicine catalog use this generic:
| Brand | Composition | Maker | Pack |
|---|---|---|---|
| A Pan 40mg Tablet | Pantoprazole (40mg) | Aknil Biotech | strip of 10 tablets |
| A Zol 40mg Tablet | Pantoprazole (40mg) | Bio-Swiss Pharma | strip of 10 tablets |
| Aar-Zole 40mg Injection | Pantoprazole (40mg) | Alpha Aromatic Pvt Ltd | vial of 1 Powder for Injection |
| Aardom 40mg Tablet | Pantoprazole (40mg) | Aar Biosys | strip of 10 tablets |
| Aarpen 40mg Injection | Pantoprazole (40mg) | Aarcin Pharmaceutical LLP | vial of 1 Injection |
| Abi-Pan Injection | Pantoprazole (40mg) | Abiba Pharmacia Pvt Ltd | vial of 1 Injection |
| Abipan 40mg Injection | Pantoprazole (40mg) | Abia Pharmaceuticals Pvt. Ltd. | vial of 1 Injection |
| Abipan Tablet | Pantoprazole (40mg) | Abia Pharmaceuticals Pvt. Ltd. | strip of 10 tablets |
| Abipanta 40mg Tablet | Pantoprazole (40mg) | Lancer Health Care Pvt Ltd | strip of 10 tablets |
| Abpent 40mg Injection | Pantoprazole (40mg) | American Biocare | vial of 1 Injection |
| Abpent 40mg Tablet | Pantoprazole (40mg) | American Biocare | strip of 10 tablets |
| Abropan 40mg Tablet | Pantoprazole (40mg) | Arbro Pharmaceuticals Pvt Ltd | strip of 10 tablets |
| Absopan 40mg Tablet | Pantoprazole (40mg) | Jupiter Biolabs Pvt Ltd | strip of 10 tablets |
| Accipent 40mg Injection | Pantoprazole (40mg) | Accilex Nutricorp | vial of 1 Injection |
| Acdof 40mg Injection | Pantoprazole (40mg) | Alkem Laboratories Ltd | vial of 1 Injection |
| Achpan 40mg Injection | Pantoprazole (40mg) | Albero Pharma Private Limited | vial of 1 Injection |
| Aciban 20 Tablet | Pantoprazole (20mg) | Cadila Pharmaceuticals Ltd | strip of 10 tablets |
| Aciban 40 Tablet | Pantoprazole (40mg) | Cadila Pharmaceuticals Ltd | strip of 10 tablets |
| Aciban 40mg Injection | Pantoprazole (40mg) | Cadila Pharmaceuticals Ltd | vial of 10 ml Injection |
| Acicare 40mg Tablet | Pantoprazole (40mg) | Siochem Pharma Pvt Ltd | strip of 10 tablets |
| Acicool P 40mg Tablet | Pantoprazole (40mg) | Biologic Psychotropics India Pvt Ltd | strip of 10 tablets |
| Acicros 40mg Tablet | Pantoprazole (40mg) | Sunberry Lifesciences Private Limited | strip of 10 tablets |
| Acicurb 40mg Tablet | Pantoprazole (40mg) | Meditune Healthcare Pvt Ltd | strip of 10 tablets |
| Acidcut Injection | Pantoprazole (40mg) | Hebert Biotech | vial of 1 Injection |
| Acidcut Tablet | Pantoprazole (40mg) | Hebert Biotech | strip of 10 tablets |
| Aciden 40mg Tablet | Pantoprazole (40mg) | Eden Pharmaceuticals Limited | strip of 10 tablets |
| Acidez-P 40mg Tablet | Pantoprazole (40mg) | Addii Biotech Pvt Ltd | strip of 10 tablets |
| Acidopent 40mg Injection | Pantoprazole (40mg) | Mediheal Remedies | vial of 1 Injection |
| Acidopent 40mg Tablet | Pantoprazole (40mg) | Medihealth Lifesciences Pvt. Ltd. | strip of 10 tablets |
| Acifear 40mg Injection | Pantoprazole (40mg) | Gaenr Biotec | vial of 1 Injection |
Showing 30 of 2631 catalog products. Search the full catalog in the app.
Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.
Storage Store pantoprazole sodium delayed-release tablets at 20° to 25°C (68° to 77°F);
Storage information from the U.S. FDA-approved label.
Pantoprazole is recorded in the NepalDoc medicine catalog for: Peptic ulcer disease, H. pylori infection, Gastro-oesophageal reflux disease, Zollinger-Ellison syndrome, Oesophagitis, Acid-related dyspepsia.
For Peptic ulcer disease: Rabeprazole.
For H. pylori infection: Omeprazole, Rabeprazole, Ranitidine.
For Gastro-oesophageal reflux disease: Lansoprazole, Omeprazole, Rabeprazole.
For Zollinger-Ellison syndrome: Famotidine, Omeprazole, Ranitidine.
For Oesophagitis: Omeprazole.
For Acid-related dyspepsia: Lansoprazole, Omeprazole.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.